NHLBI TOPMed: Severe Asthma Research Program (SARP)
Anthropometry (1)
- BMI - Body mass index (phv00420851.v2.p2)
Biomarkers (1)
- IgE - IgE, Blood (phv00420853.v2.p2)
Demographics (3)
- Age_Enroll - Age at enrollment into SARP (phv00420846.v2.p2)
- ageasthonset - Age when first diagnosed with asthma: Medical Hx (phv00420864.v2.p2)
- gender - Gender: Demographic (phv00420848.v2.p2)
Disease Events (1)
- Asthma_Duration - Duration of asthma (phv00420847.v2.p2)
General Health (5)
- ervisit - ER or urgent care visits for asthma in last year: Screening Questionnaire (phv00420862.v2.p2)
- N_ERBreathe12 - Visited ER for breathing problems in last 12 months: Medical Hx (phv00420854.v2.p2)
- N_HospBreathe12 - Spent night in hospital for breathing problems in last 12 months: Medical Hx (phv00420855.v2.p2)
- N_ICUAsthLstYear - ICU admission in last 12 months because of asthma: Medical Hx (phv00420871.v2.p2)
- N_ICUAsthma - Ever had ICU admission because of asthma: Medical Hx (phv00420856.v2.p2)
Imaging (1)
- ANALYTE_TYPE - Analyte Type (phv00420874.v1.p2)
Medications (4)
- bursts - 3+ oCS bursts in last year: Screening Questionnaire (phv00420860.v2.p2)
- icort - Take high-dose iCS: Screening Questionnaire (phv00420861.v2.p2)
- Total_iCS - Any iCS use (phv00420858.v2.p2)
- Total_OtherCS - Other CS use: oral or injected (phv00420859.v2.p2)
Race and Ethnicity (2)
- ethnic - NIH ethnic category: Demographic (phv00420850.v2.p2)
- rebackgrnd - Your racial/ethnic background: Demographic (phv00420849.v2.p2)
Respiratory (7)
- aveniox - ENO, online, Exhaled Nitric Oxide (phv00420852.v2.p2)
- Baseline_preDrug_FEV1_FVC - Baseline predrug FEV1/FVC (phv00420867.v2.p2)
- Baseline_preDrug_FEV1pp - Baseline predrug FEV1, % predicted (phv00420865.v2.p2)
- Baseline_preDrug_FVCpp - Baseline predrug FVC, % predicted (phv00420866.v2.p2)
- maxFEV1_Reversal - Maximum FEV1 reversal: Spirometry + maxBD (phv00420870.v2.p2)
- maxFEV1pp_MPVLung - Maximum FEV1 % predicted: Spirometry + maxBD (phv00420868.v2.p2)
- maxFVCpp_MPVLung - Maximum FVC % predicted: Spirometry + maxBD (phv00420869.v2.p2)
Other (17)
- BODY_SITE - Body site where sample was collected (phv00420873.v1.p2)
- CONSENT - Consent group as determined by DAC (phv00420840.v2.p2)
- Funding_Source - Project funding source (phv00420877.v1.p2)
- IS_TUMOR - Tumor status (phv00420875.v1.p2)
- N_VentAsthma - Ever had intubation or assisted ventilation because of asthma: Medical Hx (phv00420857.v2.p2)
- SAMPLE_ID - Sample ID (phv00420872.v1.p2)
- SAMPLE_ID - Sample ID (phv00420843.v2.p2)
- SEQUENCING_CENTER - Name of the center which conducted sequencing (phv00420876.v1.p2)
- SOURCE_SUBJECT_ID - Subject ID used in the Source Repository (phv00420841.v2.p2)
- Study_Name - TOPMed-assigned short study name (1:1 with TOPMed phs number) (phv00420880.v1.p2)
- subjclass_screen - Subject classification: Screening Questionnaire (phv00420863.v2.p2)
- SUBJECT_ID - Subject ID (phv00420845.v2.p2)
- SUBJECT_ID - Subject ID (phv00420839.v2.p2)
- SUBJECT_ID - Subject ID (phv00420844.v2.p2)
- SUBJECT_SOURCE - Source repository where subjects originate (phv00420842.v2.p2)
- TOPMed_Phase - TOPMed Phase (phv00420878.v1.p2)
- TOPMed_Project - TOPMed Project that funded sequencing (phv00420879.v1.p2)